New institute for hospice and palliative care
Publisher:
Future MedicineDate published:
14 January, 2009Region:
International Publication type:
researchPublication link:
New institute for hospice and palliative careFeatured item on home page:
no
We have proposed that there are two distinct sets of risk factors for Alzheimer’s disease (AD), those for the pathology of the disease and those for its clinical expression. Although Alzheimer pathology is necessary for the diagnosis, it likely is not sufficient. Autopsy studies have shown that approximately a third of individuals meeting strict criteria for neuropathological AD remain nondemented at the time of their death. Furthermore, people with similar severities of Alzheimer pathology have a very wide distribution of cognitive presentations before death, ranging from intact cognitive function to severe dementia.
Similar entries
- Factors associated with resistance to dementia despite high Alzheimer disease pathology
- Oxidative Stress in Vascular Dementia and Alzheimer's Disease: A Common Pathology
- Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer’s disease
- Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model...
- Early detection of mild cognitive impairment and alzheimer’s disease: an example using the CANTAB PAL
- Longitudinal Study of the Transition From Healthy Aging to Alzheimer Disease
- Posterior Cortical Atrophy: A Rare Form of Dementia with in vivo Evidence of Amyloid-β Accumulation
- Positive Interim results from trial of Amtloid Imaging Agent Florbetapir F18
- fMRI: use in early Alzheimer’s disease and in clinical trials
- Towards defining the neuropathological substrates of vascular dementia






